Scientific Name and Synonyms: The product in focus is Bifidobacterium breve KCTC 3419. This probiotic strain is also commonly referred to by its synonyms such as B. breve, which is a well - known member of the Bifidobacterium genus.
Microbial Classification: It belongs to the Actinobacteria phylum, Bifidobacteriaceae family, and Bifidobacterium genus. This classification places it among a group of beneficial bacteria that play crucial roles in various biological processes.
Natural Habitat and Ecological Role: Bifidobacterium breve KCTC 3419 is typically found in the human gastrointestinal tract. It thrives in this environment and contributes to maintaining a healthy gut microbiota. In the ecosystem of the gut, it helps in the fermentation of dietary fibers and the production of short - chain fatty acids, which are essential for gut health.
Historical Significance: The discovery and study of Bifidobacterium species date back to the early 20th century. Since then, Bifidobacterium breve has been extensively researched for its probiotic properties. KCTC 3419 is a specific strain that has garnered attention for its unique characteristics and potential applications in various fields.
Current Research Trends: Presently, there is a surge of interest in the microbiome and its impact on human health. Bifidobacterium breve KCTC 3419 is at the forefront of this research. Scientists are exploring its potential to modulate the immune system, improve digestive health, and even influence metabolic processes. This strain is being investigated for its ability to produce bioactive compounds that can have therapeutic effects.
Bifidobacterium breve-KCTC 3419